Pfizer has informed that it has entered into a Business Transfer Agreement (BTA) for the transfer of the Company’s business at the Thane Plant as a going concern to Vidhi Research and Development LLP in accordance with the terms of the agreement for a lump sum consideration of Rs 178 crores. Upon the conclusion of the BTA, all current workmen at the Thane Plant shall be transferred to the buyer so as to facilitate manufacturing operations.
The above information is a part of company’s filings submitted to BSE.
